, Volume 4, Issue 1–2, pp 7–14 | Cite as

Leptin and the Pituitary

  • V. Popovic
  • S. Damjanovic
  • C. Dieguez
  • F. F. Casanueva


Although leptin was originally viewed as an antiobesity hormone, it is now evident that it may have more pleiotropic actions. Experiments in rodents have shown that leptin activates the sympathetic nervous system, is involved in regulation of blood pressure, hematopoiesis, immune function, angiogenesis and brain, bone and pituitary development. Some biological effects expected based on observations in rodents, have so far not been seen in humans. Thus due to species differences in the role of leptin it is difficult to translate the data from rodents to human physiology. Hypothalamus is the primary brain site targeted by circulating leptin, secreted by fat cells. Leptin receptor has homology to members of class I cytokine receptor family, which may imply similarities in molecular events engaged by cytokines and leptin. In view of its cytokine-like properties it is likely that leptin produced and secreted outside of fat tissue i.e. in other tissues (CNS, pituitary, ovary, placenta, etc), is a paracrine regulator. Leptin receptor isoforms, long-signaling and short-nonsignaling, have been recently localized in human pituitaries. This opens the possibility of a direct action of leptin on the pituitary. However this appears to be quite complex and is species dependent. Leptin can be synthesized by normal and tumorous pituitary cells. Leptin protein expression in pituitary adenomas is decreased compared to that in normal pituitaries. Colocalization studies with leptin and anterior pituitary cells showed that 70% of ACTH cells are positive for leptin, 21% of GH cells, 29% of LH cells, 33% of FSH cells, 32% of TSH cells, 64% folliculo-stellate cells whereas very few PRL cells were positive (3%). Leptin is stored in secretory granules and secretory cells retain leptin in granules until stimulated. This follows a different secretory pathway than in adipocytes where upon synthesis leptin is immediately released. Question to be raised is does the pituitary contribute to the body leptin pool or is its action predominantly paracrine/autocrine? Clinically based evidence from studies performed in patients harboring different functional pituitary tumors causing a state of hormonal hypersecretion (acromegaly, prolactinomas, Cushing's disease) or hypopituitarism (due to non-functioning pituitary adenomas), are in favor of a paracrine/autocrine role of the pituitary leptin. Most of the studies have shown that the link between leptin, body composition and hormones of the pituitary is indirect. Thus changes in levels of circulating leptin are most likely due to changes in the metabolic and hormonal milieu during the chronic course of the disease or chronic treatment. Furthermore, circadian rhythm of leptin, its pulsatility and gender difference are preserved in hypopituitarism as well as in patients with functional pituitary adenomas implying that intact hypothalamic-pituitary function is not essential for leptin's circadian rhythm.

leptin pituitary paracrine action 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lonqvist F, Armer P, Nordfors L, Schalling M. Over-expression of the obese(Ob) gene in adipose tissue of human obese subjects.Nat Med1995;1:950-953.Google Scholar
  2. 2.
    Havel P, Kasim-Karakas S, Dubuc G, Mueller W, Phinney S. Gender difference in plasma leptin concentrations.Nat Med 1996;2:949-950.Google Scholar
  3. 3.
    Behre H, Simoni M, Nieschlag E.Strong association between serum levels of leptin and tesosterone in men. Clin Endocrinol (Oxf) 1997;47:237-240.Google Scholar
  4. 4.
    Miyakawa M, Tsushima T, Murakami H, Osizaki O, Demura H, Tanaka T. Effect of growth hormone (GH) on serum concentrations of leptin: Study in patients with acromegaly and GHdeficiency.J Clin Endocrinol Metab 1998;83:3476-3479.Google Scholar
  5. 5.
    Papaspyrou Rao S, Schneider S, Petersen R, Fried S. Dexamethasone increases leptin expression in humans in vitro. J Clin Endocrinol Metab 1997;82:1635-1637.Google Scholar
  6. 6.
    Boden G, Chen X, Kolanczynski J, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997;100:1107-1113.Google Scholar
  7. 7.
    Shimizu H, Shiommura Y, Nakanishi0 Y, Futawatari T, Ohtani K, Sato N, Mori M. Estrogen increase in vivo leptin production in rats and human subjects. J Endocrinol 1997; 154:285-292.Google Scholar
  8. 8.
    Isidori A, Strollo F, More M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A. Leptin and aging:correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000;85:1954-1962.Google Scholar
  9. 9.
    Kalra S, Dube M, Pu S, Xu B, Horvath T, Kalra P. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight.Endocrine Rev 1999;20:68-100.Google Scholar
  10. 10.
    Ozata M, Ozdemir C, Licinio J. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin and spontaneous correction of leptin mediated defects. J Clin Endocrinol Metab 1999;84:3686-3696.Google Scholar
  11. 11.
    Reichlin S. Is leptin a secretion of the brain? J Clin Endocrinol Metab 1999;84:2267-2269.Google Scholar
  12. 12.
    Licinio J, Mantzoros C, Negrao A, et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997;3:575-579.Google Scholar
  13. 13.
    Suter K, Pohl C, Wilson M. Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: Potential signals fore the initiation of puberty. J Clin Endocrinol Metab 2000;85:808-814.Google Scholar
  14. 14.
    Flier J. What's in a name? In search of Leptin's physiologic role.J Clin Endocrinol Metab 1998;83:1407-1413.Google Scholar
  15. 15.
    Wiesner G, Vaz M, Collier G, Seals D, Kaye D, Jennings G, Lambert G, Wilkinson D, Esler M. Leptin is released from the human brain: In_uence of adiposity and gender. J Clin Endocrinol Metab 1999;84:2270-2274.Google Scholar
  16. 16.
    Morash B, Li A, Murphy P, Wilkinson M, Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology 1999;140:5995-5998.Google Scholar
  17. 17.
    Shimon I, Yan X, MaGoffin D, Fiedman T, Melmed S. Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. J Clin Endocrinol Metab 1998;83:4059-4064.Google Scholar
  18. 18.
    Jin L, Burguera B, Couce M, Sheithauer B, Lamsan J, Eberhardt N, Kulig E, Lloyd R. Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999;84:2903-2911.Google Scholar
  19. 19.
    Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.Google Scholar
  20. 20.
    O'Rahilly S. Life without leptin. Nature 1998;392:330-331.Google Scholar
  21. 21.
    Farooqui I, Jebb S, Langmark G, Lawrence E, Cheetham C, Prentice A, Hughes I, McCamish M, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Engl J Med 1999;341:879-884.Google Scholar
  22. 22.
    Schwartz J. Intercellular communication in the anterior pituitary. Endocrine Rev 2000;21:488-513.Google Scholar
  23. 23.
    Yu W, Kimura M, Walczewska A, Karanth S, McCann S. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 1997;94:1023-1028.Google Scholar
  24. 24.
    Zamorano P, Mahesh V, DeSevilla L, Chorich L, Bhat G, Brann D. Expression and localization of the leptin receptor in endocrine and neurendocrine tissues of the rat. Neuroendocrinology 1997;65:223-228.Google Scholar
  25. 25.
    Jin L, Zhang S, Burguera B, Couce M, Osamura R, Kulig E, Lloyd R. Leptin and leptin receptor expression in rat and mouse pituitary cells. Endocrinology 2000;141:333-339.Google Scholar
  26. 26.
    Iqbal J, Pompolo S, Considine R, Clarke I. Localization of leptin receptor-like immunoreactivity in the corticotropes, somatotropes and gonadotropes in the ovine anterior pituitary. Endocrinology 2000;141:1515-1520.Google Scholar
  27. 27.
    Natagani S, Zeng Y, Keisler D, Foster D, Jaffe C. Leptin regulates pulsatile luteinizing hormone and growth hormone secretion in the sheep. Endocrinology 2000;141:3965-3975.Google Scholar
  28. 28.
    Vidal S, Cohen S, Horvath E, Kovacs K, Scheithauer B, Burguera B, Lloyd R. Subcellular localization of leptin in non-tumorous and adenomatous human pituitaries: An immuno-ultrastructural study.J Histochem Cytochem 2000; 48:1147-1152.Google Scholar
  29. 29.
    Carro E, Senaris R, Considine R, Casanueca F, Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997;138:2203-2206.Google Scholar
  30. 30.
    Casanueva F, Dieguez C. Interaction between body composition, leptin and growth hormone status. Bailliere Clin Endocrinol Metab 1998;12:297-314.Google Scholar
  31. 31.
    Dieguez C, Carro E, Seoane L, Garcia M, Camina J, Senaris R, Popovic V, Casanueva F. Regulation of somatotroph cell function by the adipose tissue. Int J Obesity 2000;24,Suppl2: S100-S103.Google Scholar
  32. 32.
    Damjanovic S, Petakov M, Raicevic S, Micic D, Marinkovic J, Dieguez C, Casanueva F, Popovic V. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by transsphenoidal surgery. J Clin Endocrinol Metab 2000;85:147-154.Google Scholar
  33. 33.
    Gualillo O, Lago F, Garcia M, Menendez C, Senaris R, Casanueva F, Dieguez C. Prolactin stimulates leptin secretion by rat white adipose tissue. Endocrinology 1999;140:-5149-5153.Google Scholar
  34. 34.
    Mukherjea R, Castonguay T, Douglass T, Moser Veillon P. Elevated leptin concentrations in pregnancy and lactation: possible role as a modulator of substrate utilization. Life Sci 1999;65:1183-1193.Google Scholar
  35. 35.
    Simic M, Pekic S, Zarkovic M, Damjanovic S, Petakov M, Djurovic M, Medic M, Dieguez C, Casanueva F. Prolactin, leptin and body weight in patients with prolactin secreting pituitary adenomas successfully treated with bromocriptine. Pituitary, Vol 3:2000; Abstract OC2 page 17. Abstracts from the 7th European Workshop on Pituitary Disease 10-13 Sept. Oxford, 2000.Google Scholar
  36. 36.
    Leal-Cerro A, Considine R, Peino R, Venegas E, Astorga R, Casanueva F, Dieguez C. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome. Horm Metab Res 1996;28:711-713.Google Scholar
  37. 37.
    Cizza G, Lotsikas A, Licinio J, Gold P, Chrousos G. Plasma leptin levels do not change in patients with Cushing's disease shorthly after correction of hypercortisolism. J Clin Endocrinol Metab 1997;82:2747-2750.Google Scholar
  38. 38.
    Butzow T, Moilanen J, Lehovirta M, Tuomi T, Hovatta O, Siegberg R, Nilsson CG, Apter D. Serum and follicular _uid leptin during in vitro fertilization: Relationship among leptin increase, body fat mass and reduced ovarian response. J Clin Endocrinol Metab 1999;84:3135-3139.Google Scholar
  39. 39.
    Al-Shoumer K, Anaoku V, Richmond W, Johnston D. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1997;47:153-159.Google Scholar
  40. 40.
    Gill M, Toogood A, O'Niell P, Adams J, Thorner M, Shalet S, Clayton P. Leptin and body composition in healthy and GH de~cient elderly subjects. Clin Endocrinol (Oxf) 1997;47: 161-167.Google Scholar
  41. 41.
    Janssen Y, Frolich M, Deurenberg P, Roelfsema F. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. Eur J Endocrinol1997;137:650-654.Google Scholar
  42. 42.
    Nystrom F, Ekman B, Osterlund M, Lindstrom T, Ohman P, Arnqvist H. Serum, leptin concentrations in normal population and in GH-deficiency: Negative correlation with testosterone in men and effects of GH treatment. Clin Endocrinol (Oxf) 1997;47:191-198.Google Scholar
  43. 43.
    Norrelund H, Gravholt C, Enlargo P, Blum W, Rascher W, Christiansen J, Jorgensen J. Increased levels but preserved diurnal variation of serum leptin in GHdeficient patients: Lack of impact of different modes of GHadministration. Eur J Endocrinol 1998;138:644-652.Google Scholar
  44. 44.
    Brennan B, Rahim A, Blum W, Adams J, Eden O, Shalet S. Hyperleptinemia in young adults following cranial irradiation in childhood: Growth hormone deficiency or leptin insensitivity. Clin Endocrinol (Oxf) 1999;50:163-169.Google Scholar
  45. 45.
    Rauch F, Westerman F, Enlargo P, Blum W, Schonau E. Serum leptin is suppressed by growth hormone therapy in growth hormone-deficient children. Horm Res 1998;50: 18-21.Google Scholar
  46. 46.
    Fisker S, Vahl N, Hansen T, Jorgensen J, Hagen C, Orskov H, Christiansen J. Serum leptin is increased in growth hormone-deficient adults: Relationship to body composition and effects of placebo-controlled growth hormone therpay for 1 year. Metabolism 1997;46:812-817.Google Scholar
  47. 47.
    Kristensen K, Pedersen S, Fisker S, Norrelund H, Rosenfalck A, Jorgensen J, Richelsen B. Serum leptin levels and leptin expression in ghrowth hormone (GH)-deficient and healthy subjects: Influence of GH treatment, gender and fasting. Metabolism1998;47:1514-1519.Google Scholar
  48. 48.
    Kousta E, Chrisoulidou A, Lawrence N, al-Shoumer K, Parker K, Mccarthy M, Johnston G. The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 1998;48:685-690.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • V. Popovic
    • 1
    • 2
  • S. Damjanovic
    • 1
    • 2
  • C. Dieguez
    • 1
    • 2
  • F. F. Casanueva
    • 1
    • 2
  1. 1.Institute of EndocrinologyUniversity Clinical Center BelgradeYugoslavia
  2. 2.Dept. of Physiology Medical Faculty and Dept. of Medicine, Endocrine Division Complejo HospitalarioUniversity Santiago de CompostelaSantiago de CompostelaSpain

Personalised recommendations